News

APP Pharma claims that Topotecan for injection is therapeutically equivalent to the reference-listed drug Hycamtin, which is currently marketed by the GlaxoSmithKline. Topotecanfor injection is indicated for small

Medivation and Astellas Pharma said that the trial is evaluating 160mg/day of MDV3100 versus placebo. Conducted at sites in the US, Canada, Europe, Australia, South America and South

Gilbreth uses multiple printing technologies as a full-service manufacturer and marketer of full body shrink sleeves (FBSS), tamper evident neck bands and medical & electronic tubing. Gilbreth leverages

Effective immediately, GeneGo will become part of the Healthcare & Science business of Thomson Reuters. The acquisition enables Thomson Reuters to provide the pharmaceutical, biotechnology, and academic research

However, if the trading price of the Dongsheng Pharma’s common stock is less than $1.50 per share on the date on which the RMB5m ($750,750) of common stock

Quintiles Global Central Laboratories senior vice president Thomas Wollman said that through their alliance with London Genetics, they have expertise to help early adopters of personalised medicine use

The Phase II trial expects to recruit approximately 650 participants at some 30 health-care centers across the US Sanofi Pasteur’s, the vaccines division of Sanofi-aventis Group, Phase II

Mymetics already uses this new production method for its Respiratory Syncytial Virus (RSV) and Herpes Simplex Virus (HSV) vaccine that are in preclinical development. The patent, which describes

Perrigo has the exclusive rights from Synthon to sell and distribute the product in the US. Synthon claims that its product is the only approved generic product having